Controversies in NMIBC: Guidelines and Beyond
Sam S. Chang, MD, MBA, discusses NMIBC guidelines, best practices, and controversies related to risk-stratification, surveillance, and treatment strategies.
Read More
2022
Lessons from Ancient Greek Physicians
Neil H. Baum, MD, reviews ancient Greek medicine and considers how early paradigm shifts continue to impact modern medicine.
Read More
Need to Know: The Impact of a Restricted Supply of Lutetium (Pluvicto)
E. David Crawford, MD; Alan H. Bryce, MD; and Bryan A. Mehlhaff, MD discuss Lutetium Lu-177, its effectiveness, manufacturing challenges, and clinical effects of today’s shortage.
Read More
Bladder Sparing Regimens for Muscle Invasive Disease: Should We Be Doing this More?
Peter Black, MD, FACS, FRCSC, discusses trimodal therapy (TMT) as a bladder-sparing option for some patients with muscle-invasive bladder cancer (MIBC).
Read More
Rationale for Focal Therapy
Samir S. Taneja, MD, describes the basis for focal therapy for prostate cancer and how to use it successfully.
Read More